entertainment -WSS

entertainment

author：leisure time 2025-08-19 18:04:31 - browse：5545

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Abortion pill Supreme Court ruling could impact entire drug industry

leisure time

WSS

Supreme Court mifepristone arguments center on docs' right to sue

Children’s Hospital revives plan for pedestrian bridge

Readout Newsletter: Beam, Prozac, "TechBio" and more

Readout LOUD podcast: mifepristone case, GLP

Merck drug for rare lung condition set for approval in U.S.

Eliminate the waiting period for sterilization covered by Medicaid

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Why the world’s most expensive drug might be worth the price

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Merck, Vertex, and Viking updates

The cancer drug shortage isn’t new — and neither are the solutions

Primary care physicians play key roles in Alzheimer's management

Tori Bowie and the unacceptable rates of Black maternal death

Oprah kicked off a national conversation on obesity. Let's have it

focus

CDC panel: People 65 and older should get a Covid spring booster shot

CDC panel: People 65 and older should get a Covid spring booster shot

Abortion pill case raises question: who can sue the FDA?

Change Healthcare cyberattack shows risk of industry consolidation

Elisabeth Bik tackles the widespread issue of research misconduct

Are embryos people? Reproductive medicine's future depends on the answer

hotspot

explore

leisure time

entertainment